A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
Clinical trial NCT05802693 · UNKNOWN
Trial details
- NCT number
- NCT05802693
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2025-11-14
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.